SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013491
Filing Date
2022-08-12
Accepted
2022-08-12 16:06:08
Documents
55
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220630x10q.htm   iXBRL 10-Q 1469181
2 EX-31.1 tmb-20220630xex31d1.htm EX-31.1 18445
3 EX-31.2 tmb-20220630xex31d2.htm EX-31.2 18503
4 EX-32.1 tmb-20220630xex32d1.htm EX-32.1 8289
5 EX-32.2 tmb-20220630xex32d2.htm EX-32.2 8777
  Complete submission text file 0001558370-22-013491.txt   5958923

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20220630.xsd EX-101.SCH 35494
7 EX-101.CAL tmb-20220630_cal.xml EX-101.CAL 49520
8 EX-101.DEF tmb-20220630_def.xml EX-101.DEF 139909
9 EX-101.LAB tmb-20220630_lab.xml EX-101.LAB 314053
10 EX-101.PRE tmb-20220630_pre.xml EX-101.PRE 254335
49 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220630x10q_htm.xml XML 1047474
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14778 | Film No.: 221160057
SIC: 2834 Pharmaceutical Preparations